"In response to the need for mRNA COVID-19 vaccines during the pandemic ... and end-to-end RNA expertise under one roof, ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus' versatile RNA therapeutics platforms can be applied toward ...

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine ...

According to a recent article in Biospace ,"The solid tumors market size reached a value of US$ 170.3 Billion in 2023. Looking forward, the market is expected to reach US$ 375.4 Billion by 2034, ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. Read our latest report on the stock here.

Aligos Therapeutics, Inc. ( (ALGS) ) has released its Q3 earnings. Here is a breakdown of the information Aligos Therapeutics, Inc. presented ...

The excitement around mRNA vaccines, particularly in the light of their success in combating COVID-19, has spurred research ...

Two Kansas State University faculty members, both from the College of Veterinary Medicine, will each receive a $5,000 award in recognition of their outstanding teaching and research.

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) on November 6 and set a ...

Request To Download Free Sample of This Strategic Report @ The publisher has been closely monitoring the various markets in Saudi Arabia Peptide Therapeutics Market. This report provides a ...